Results 281 to 290 of about 5,707,552 (346)

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

open access: yesMolecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric   +10 more
wiley   +1 more source

Automated calculation of background parenchymal enhancement as a biomarker of treatment responses and recurrence-free survival in breast cancer. [PDF]

open access: yesBreast Cancer Res Treat
Zhu Y   +10 more
europepmc   +1 more source

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

open access: yesMolecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni   +11 more
wiley   +1 more source

A model of optical pump-terahertz probe by ultrafast terahertz near-field microscopy. [PDF]

open access: yesiScience
Zhang Z   +9 more
europepmc   +1 more source

Beam commissioning of a new compact scanned proton therapy system with four different dose calculation algorithms. [PDF]

open access: yesJ Appl Clin Med Phys
Tanokura R   +12 more
europepmc   +1 more source

Generalizability of deep learning-based dose conversion model in proton beam therapy. [PDF]

open access: yesJ Appl Clin Med Phys
Kato R   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy